טוען...
Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?
Introduction: Fifty years after the discovery of Δ(9)-tetrahydrocannabinol (THC) as the psychoactive component of Cannabis, we are assessing the possibility of translating this herb into clinical treatment of inflammatory bowel diseases (IBDs). Here, a discussion on the problems associated with a po...
שמור ב:
| הוצא לאור ב: | Expert Rev Gastroenterol Hepatol |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Taylor & Francis
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5388177/ https://ncbi.nlm.nih.gov/pubmed/28276820 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/17474124.2017.1292851 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|